Back
Johnson & Johnson Vs. Rapt Therapeutics, Inc. Sector Stock Comparison
Buy
53
JNJ
Johnson & Johnson
Last Price:
$207.03
Seasonality Move:
1.72%
Sell
38
RAPT
Rapt Therapeutics, Inc.
Last Price:
$33.91
Seasonality Move:
-28.15%
Buy
53
Johnson & Johnson (JNJ)
is a Buy
Is Johnson & Johnson a Buy, Sell or Hold?
-
The current Johnson & Johnson [JNJ] share price is $206.91. The Score for JNJ is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
JNJ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Rapt Therapeutics, Inc. [RAPT] share price is $33.38. The Score for RAPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $206.91The current trend is moderately bullish and JNJ is experiencing slight buying pressure.
RAPT Stock Price Chart
What is Rapt Therapeutics, Inc.'s stock price today?
-
The Rapt Therapeutics, Inc. share price today is $33.38Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing slight buying pressure.
JNJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.08 | Buy |
| Relative Strength Index (14 RSI): | 54.74 | Buy |
| Chaikin Money Flow: | -1312465 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
RAPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.71 | Buy |
| Relative Strength Index (14 RSI): | 49.51 | Sell |
| Chaikin Money Flow: | -220916 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
JNJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 207.21 | Sell |
| 20-day SMA: | 206.82 | Buy |
| 50-day SMA: | 199.63 | Buy |
| 200-day SMA: | 173.7 | Buy |
| 8-day EMA: | 207.43 | Sell |
| 20-day EMA: | 206.29 | Buy |
| 50-day EMA: | 200.31 | Buy |
| 200-day EMA: | 180.03 | Buy |
RAPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.03 | Sell |
| 20-day SMA: | 34.65 | Sell |
| 50-day SMA: | 31.71 | Buy |
| 200-day SMA: | 16.89 | Buy |
| 8-day EMA: | 31.26 | Buy |
| 20-day EMA: | 20.72 | Buy |
| 50-day EMA: | 10.54 | Buy |
| 200-day EMA: | 3 | Buy |
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and an increase next year of $0.86 per share.
Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $1.22 per share.
Johnson & Johnson Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rapt Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||